Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuebijing infusion for diaphragmatic function in critically ill patients with sepsis
ChiCTR1800016065Phase 4Recruiting
- Sponsor
- Yejishan Hospital of Wannan Medical College
- Start
- May 2018
- Countries
- 1
01
Overview
Phase 4, open-label trial of xuebijing in sepsis (2 arms), sponsored by Yejishan Hospital of Wannan Medical College. Primary endpoint: Diaphragmatic function. Started May 2018; status: recruiting.
02
Drugs
xuebijing
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR1800016065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016065.